Risk factor
Limited trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Humedix Co., Ltd. is a South Korean healthcare enterprise engaged in the research, development, production, and distribution of a diverse array of pharmaceutical goods. Its comprehensive portfolio encompasses non-prescription and prescription medications, active pharmaceutical ingredients, and medical equipment. Beyond pharmaceuticals, the company also supplies cosmetic items, advanced functional synthetic materials, and health-enhancing dietary supplements. Founded in 2002, Humedix Co., Ltd. is headquartered in Anyang-si, South Korea, and was previously known as HVLS Co., Ltd. before adopting its current name in 2010.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD